Association of low-density lipoprotein receptor genotypes with hepatitis C viral load

Soluble LDLR can inhibit HCV infectivity; greater plasma low-density lipoprotein levels are associated with treatment success; LDLR genotypes have a synergistic impact on the likelihood of achieving SVR with Peg-IFN plus RBV, as well as on viral kinetics after starting treatment.

http://ift.tt/1cYWlFB